The physicians, each widely published with significant academic and research experience, will take on the duties of keeping Relatable’s leadership informed on physician perspectives of big data’s utility in healthcare.

Covid-19 negatively impacted healthcare facilities around the country, and CMS altered reimbursement rates for 2021. With margins thinning rapidly, how can facilities maintain anything close to pre-pandemic profitability?

Relatable Healthcare helps device companies and their reps generate high potential sales leads.

What is it? Where does it come from? And why do we need it?

Depending on your role in the healthcare system, your answer may vary.

Current volatility and the upcoming surge and shift in elective surgeries is forcing medical device company leaders to rethink existing business models.

“Flatten the curve” has become the mantra of Covid-19 response resulting in stay-at-home advisories excluding essential travel, social distancing, and postponing elective surgeries.

Bain & Company's research suggests that surgeons at ASCs are more likely to change medical devices than their peers within hospital settings.